🇺🇸 FDA
Patent

US 7534440

Fusion molecules and methods for treatment of immune diseases

granted A61KA61K2039/505A61P

Quick answer

US patent 7534440 (Fusion molecules and methods for treatment of immune diseases) held by The Regents of the University of California expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2039/505, A61P, A61P1/04, A61P1/08